AURA Automated IVF Lab

About Conceivable Life Sciences

Conceivable Life Sciences is developing AURA, an integrated, automated platform designed to perform all key functions of an IVF laboratory, from sperm processing to embryo vitrification. Founded in 2021, the company addresses a massive unmet need in fertility care, where an estimated 95% of those needing IVF cannot access it due to high costs and manual, unscalable processes. With a $50M Series A raise and an initial clinical validation site operational in Mexico City, Conceivable is positioning its automated lab as a scalable solution for IVF clinics, aiming to transform a largely artisanal practice into a standardized, high-throughput service. The long-term vision is to make IVF a more affordable and accessible therapy for millions worldwide.

Therapeutic Areas